Pharming Group Nv Stock Analysis
| PHAR Stock | USD 9.80 0.43 4.20% |
Pharming Group NV is overvalued with Real Value of 8.46 and Hype Value of 9.8. The main objective of Pharming Group stock analysis is to determine its intrinsic value, which is an estimate of what Pharming Group NV is worth, separate from its market price. There are two main types of Pharming Group's stock analysis: fundamental analysis and technical analysis.
The Pharming Group stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Pharming Group is usually not traded on Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day. Pharming Stock trading window is adjusted to America/New York timezone.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharming Group NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. Pharming Stock Analysis Notes
The book value of the company was at this time reported as 0.32. The company recorded a loss per share of 0.21. Pharming Group NV had not issued any dividends in recent years. Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. Pharming Group N.V. is headquartered in Leiden, the Netherlands. Pharming Group operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 277 people. To find out more about Pharming Group NV contact MBA MD at 31 71 524 7400 or learn more at https://www.pharming.com.Pharming Group NV Investment Alerts
| Pharming Group NV had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 297.2 M. Net Loss for the year was (10.64 M) with profit before overhead, payroll, taxes, and interest of 285.37 M. | |
| Pharming Group NV currently holds about 189.96 M in cash with (1.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.91. |
Pharming Group NV Upcoming and Recent Events
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Pharming Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 699.33 M.Pharming Profitablity
The company has Profit Margin (PM) of (0.04) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.01 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.01.Technical Drivers
As of the 23rd of July, Pharming Group holds the Risk Adjusted Performance of 0.0736, semi deviation of 3.27, and Coefficient Of Variation of 1371.51. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pharming Group, as well as the relationship between them. Please check Pharming Group NV standard deviation, as well as the relationship between the maximum drawdown and expected short fall to decide if Pharming Group NV is priced some-what accurately, providing market reflects its current price of 9.8 per share. Given that Pharming Group has jensen alpha of 0.1467, we recommend you to check out Pharming Group NV's recent market performance to make sure the company can sustain itself at a future point.Pharming Group NV Price Movement Analysis
The output start index for this execution was eight with a total number of output elements of fifty-three. The Simple Moving Average indicator is calculated by adding the closing price of Pharming Group for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Pharming Group NV short-term fluctuations and highlight longer-term trends or cycles.
Pharming Group NV Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Pharming Group insiders, such as employees or executives, is commonly permitted as long as it does not rely on Pharming Group's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Pharming Group insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Camden Partners Strategic Fund Ii A Lp over six months ago Acquisition by Camden Partners Strategic Fund Ii A Lp of 5000 shares of Pharming Group at 0.68 subject to Rule 16b-3 |
Pharming Group Outstanding Bonds
Pharming Group issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pharming Group NV uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pharming bonds can be classified according to their maturity, which is the date when Pharming Group NV has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| PHARMACIA P 66 Corp BondUS71713UAW27 | View | |
| PHARMACIA P 675 Corp BondUS71713UAT97 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Pharming Group Predictive Daily Indicators
Pharming Group intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Pharming Group stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Pharming Group Forecast Models
Pharming Group's time-series forecasting models are one of many Pharming Group's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pharming Group's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Pharming Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Pharming Group prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pharming shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pharming Group. By using and applying Pharming Stock analysis, traders can create a robust methodology for identifying Pharming entry and exit points for their positions.
Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. Pharming Group N.V. is headquartered in Leiden, the Netherlands. Pharming Group operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 277 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Pharming Group to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
| All Next | Launch Module |
Additional Tools for Pharming Stock Analysis
When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.